Rays of Belief IPO  Logo

Rays of Belief IPO

Live Updates, GMP, Subscription Data, and Financial Details

IPO Overview

Listed
Dates Sep 01 to Sep 03 2026
Price Band ₹227 - 239
Current GMP ₹239 (0.00%)
Subscription 107.71 times

IPO Details

IPO Date
1 to 3 Sep, 2026
Listing Date
Tue, Sep 8, 2026
Face Value
₹ 10 per share
Price Band
₹227 to ₹239
Issue Price
₹239 per share
Lot Size
62 Shares
Sale Type
Fresh capital only
Issue Type
Bookbuilding IPO
Listing At
BSE, NSE
Total Issue Size
52,30,000 shares (agg. up to ₹ 125 Cr)
Fresh Issue
52,30,000 shares (agg. up to ₹ 125 Cr)
Share Holding Pre Issue
1,56,71,682 shares
Share Holding Post Issue
2,09,01,682 shares
BSE Script Code / NSE Symbol
544906 / MOMSBELIEF
ISIN
INE1FCO01014

IPO Subscription Details

Anchor
1
QIB (Ex Anchor)
9.06
NII
279.11
bNII (> ₹10L)
303.82
sNII (< ₹10L)
229.70
Retail
195.86
Total **
107.71

Day Wise Sub

DaySep 1 (Day 1)
QIB (Ex Anchor)0.00
NII0.39
NII (> ₹10L)0.13
NII (< ₹10L)0.90
Retail6.51
Total1.18
DaySep 2 (Day 2)
QIB (Ex Anchor)0.01
NII2.07
NII (> ₹10L)1.12
NII (< ₹10L)3.98
Retail18.67
Total3.63
DaySep 3 (Day 3)
QIB (Ex Anchor)9.06
NII279.11
NII (> ₹10L)303.82
NII (< ₹10L)229.70
Retail195.86
Total107.71

Day Wise GMP

GMP Date08-09-2026
IPO Price239
GMP15 (6.28%)
Est. Listing Price254
GMP Date07-09-2026
IPO Price239
GMP15 (6.28%)
Est. Listing Price254
GMP Date06-09-2026
IPO Price239
GMP20 (8.37%)
Est. Listing Price259
GMP Date05-09-2026
IPO Price239
GMP10 (4.18%)
Est. Listing Price249
GMP Date04-09-2026
IPO Price239
GMP12 (5.02%)
Est. Listing Price251
GMP Date03-09-2026
IPO Price239
GMP12 (5.02%)
Est. Listing Price251
GMP Date02-09-2026
IPO Price239
GMP42 (17.57%)
Est. Listing Price281
GMP Date01-09-2026
IPO Price239
GMP38 (15.90%)
Est. Listing Price277
GMP Date31-08-2026
IPO Price239
GMP48 (20.08%)
Est. Listing Price287
GMP Date30-08-2026
IPO Price239
GMP35 (14.64%)
Est. Listing Price274
GMP Date29-08-2026
IPO Price239
GMP26 (10.88%)
Est. Listing Price265
GMP Date28-08-2026
IPO Price239
GMP29 (12.13%)
Est. Listing Price268
GMP Date27-08-2026
IPO Price239
GMP10 (4.18%)
Est. Listing Price249
GMP Date26-08-2026
IPO Price239
GMP18 (7.53%)
Est. Listing Price257
GMP Date25-08-2026
IPO Price239
GMP0 (0%)
Est. Listing Price239
GMP Date24-08-2026
IPO Price239
GMP0 (0%)
Est. Listing Price239
GMP Date23-08-2026
IPO Price0
GMP0 (0%)
Est. Listing Price0
GMP Date22-08-2026
IPO Price0
GMP0 (0%)
Est. Listing Price0
GMP Date21-08-2026
IPO Price0
GMP0 (0%)
Est. Listing Price0
GMP Date20-08-2026
IPO Price0
GMP0 (0%)
Est. Listing Price0

IPO Important Dates

IPO Open
Tue, Sep 1, 2026
IPO Close
Thu, Sep 3, 2026
Allotment
Fri, Sep 4, 2026
Refund
Mon, Sep 7, 2026
Credit of Shares
Mon, Sep 7, 2026
Listing
Tue, Sep 8, 2026

IPO Lot Size

ApplicationRetail (Min)
Lots1
Shares62
Amount₹14,818
ApplicationRetail (Max)
Lots13
Shares806
Amount₹1,92,634
ApplicationS-HNI (Min)
Lots14
Shares868
Amount₹2,07,452
ApplicationS-HNI (Max)
Lots67
Shares4,154
Amount₹9,92,806
ApplicationB-HNI (Min)
Lots68
Shares4,216
Amount₹10,07,624

Financial Information

Period EndedAssets
31 Mar 202650.89
31 Mar 202526.12
31 Mar 202412.89
Period EndedTotal Income
31 Mar 202682.06
31 Mar 202536.54
31 Mar 202430.76
Period EndedProfit After Tax
31 Mar 20264.96
31 Mar 20255.88
31 Mar 20240.85
Period EndedEBITDA
31 Mar 202611.91
31 Mar 20253.02
31 Mar 20241.49
Period EndedNET Worth
31 Mar 202630.81
31 Mar 202515.02
31 Mar 20245.78
Period EndedReserves and Surplus
31 Mar 202615.22
31 Mar 202514.70
31 Mar 20245.47
Period EndedTotal Borrowing
31 Mar 20263.61
31 Mar 20254.36
31 Mar 2024

Key Performance Indicator

ROE
21.64%
ROCE
29.74%
Debt/Equity
0.12
RoNW
21.64%
PAT Margin
6.07%
EBITDA Margin
14.59%
NAV
15.67
Price to Book Value

IPO Reservation

QIB
39,22,500
− Anchor Investor
20,92,190
− QIB (Ex. Anchor)
18,30,310
NII (HNI)
7,84,500
− bNII > ₹10L
5,23,000
− sNII < ₹10L
2,61,500
Retail
5,23,000
Total
52,30,000

Information about company

Incorporated in 2017, Rays of Belief Ltd. is a for-profit social enterprise providing personalised intervention plans for children with Neurodevelopmental Disorders (NDDs), including Autism Spectrum Disorder (ASD), ADHD, Down Syndrome, Cerebral Palsy, Intellectual Disability, Learning Disabilities and Global Developmental Delays. The Company started its first centre in Gurgaon in 2018 and has since expanded from 71 centres in Fiscal 2023 to 136 centres as of March 31, 2026, under its brand name Mom’s Belief. These centres are spread across 57 cities and 20 states and union territories in India, with a strong presence in Tier 2 cities. The network includes 42 Tier 1, 77 Tier 2 and 17 Tier 3 centres, helping extend developmental care to underserved and semi-urban areas. The Company primarily serves children aged 18 months to 12 years, while specialised programs are available for children up to 15 years, focusing on vocational and life skills. Its multidisciplinary services include early intervention, parental guidance, occupational therapy, language therapy and family support programs. The centres are equipped with 150+ teaching tools, while home-based learning kits provide access to 2,000+ teaching tools, supported by regular follow-ups and progress monitoring. As of March 31, 2026, the Company had a team of 340+ full-time clinical professionals. In June 2025, Rays of Belief Ltd. acquired Mom's Belief US, Inc. as its wholly owned subsidiary and Allergy and Immunology Virginia, LLC as its step-down subsidiary in the USA. The acquisition added three centres in Virginia, located in Salem, Lynchburg and Roanoke.

Objectives of IPO

The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: #: Issue Objects 1: Company Learning Centres and Company Learning Centres in partnership with Licensed Professionals 2: School Collaboration Centres 3: Centre for Excellence and Research 4: Upskilling Academy 5: Technology (hardware) costs 6: Expenditure for lease payments for existing centres in India 7: Investment in Subsidiary, Moms Belief US Inc., for making lease / license payments for existing centres in the USA 8: Expenditure for brand awareness and inclusive outreach programs 9: Funding inorganic growth through unidentified acquisition and General corporate purposes 10: Issue Expenses : Total

Disclaimer

All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application. No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever Please read all Tearms and conditions , and agree to use the App